Dr. Ahmad Abdulaziz S Almutlaq

MBBS | Neurology


  3201 Race St Apt 812, Philadelphia
     Pennsylvania, 19104-3698
  267-245-4631    Maps & Directions
Dr. Ahmad Abdulaziz S Almutlaq is a Philadelphia, Pennsylvania based neurologist who is specialized in Neurology. His current practice location is 3201 Race St Apt 812, Philadelphia. Patients can reach him at 267-245-4631. Dr. Ahmad Abdulaziz S Almutlaq is MBBS in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1295400638.
Dr. Ahmad Abdulaziz S Almutlaq specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Ahmad Abdulaziz S Almutlaq speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Ahmad Abdulaziz S Almutlaq
Specialization: Neurology
Gender:Male
Credentials: MBBS
Practice Address:3201 Race St Apt 812, Philadelphia,
Pennsylvania, 19104-3698
Phone:267-245-4631
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1295400638
NPI Enumeration Date: 09 Aug, 2021
NPI Last Update On: 09 Aug, 2021

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Ahmad Abdulaziz S Almutlaq
3201 Race St Apt 812,
Philadelphia, Pennsylvania
Zip: 19104-3698
Patients can reach Dr. Ahmad Abdulaziz S Almutlaq at 3201 Race St Apt 812, Philadelphia, Pennsylvania or can call to book an appointment on 267-245-4631.
Comments/ Reviews:

*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.